Proteome Sciences Plc (PRM.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 10-1994 | |
| Cash Flows From Operating Activities | |
| Accounts receivable | -813 |
| Other Working Capital | -789 |
| Other Operating Activity | 793 |
| Operating Cash Flow | $-809 |
| Cash Flows From Investing Activities | |
| Net Acquisitions | 50 |
| Investing Cash Flow | $50 |
| Cash Flows From Financing Activities | |
| Debt Issued | 1,100 |
| Common Stock Issued | 13 |
| Financing Cash Flow | $1,113 |
| End Cash Position | 354 |
| Net Cash Flow | $354 |
| Free Cash Flow | |
| Operating Cash Flow | -809 |
| Free Cash Flow | -809 |